Inhibition of NHE-1 Na+/H+ exchanger by natriuretic peptides in ocular nonpigmented ciliary epithelium

American Journal of Physiology - Cell Physiology

Volumn 287, Issue 3 56-3, 2004, Pages

  Fidzinski, Pawel ^a   Salvador Silva, Mercedes ^a   Choritz, Lars ^a   Geibel, John ^a   Coca Prados, Miguel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aqueous humor; Intracellular pH; Na+ H+ exchanger type 1

Indexed keywords

18ALPHA GLYCYRRHETINIC ACID; 5 (N ETHYL N ISOPROPYL)AMILORIDE; 8 BROMO CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; PROTEIN INHIBITOR; SODIUM PROTON EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL PH; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; EYE DISEASE; FLUID TRANSPORT; GAP JUNCTION; HYDROLYSIS; HYPOTENSION; INHIBITION KINETICS; INTRAOCULAR PRESSURE; MAMMAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM;

ANIMALS; AQUEOUS HUMOR; CATTLE; CILIARY BODY; FLUORESCENT ANTIBODY TECHNIQUE; HYDROGEN-ION CONCENTRATION; INTRAOCULAR PRESSURE; NATRIURETIC PEPTIDES; PIGMENT EPITHELIUM OF EYE; PROTEIN ISOFORMS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM-HYDROGEN ANTIPORTER;

ANIMALIA; MAMMALIA;

EID: 4143112308     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00552.2003     Document Type: Article

References (49)

1. Abbey SE and Potter LR. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B. Endocrinology 144: 240-246, 2003.
2. + exchanger in renal microvillus membrane vesicles. Nature 299: 161-163, 1982.
3. + exchange reduce mouse intraocular pressure. Invest Ophthalmol Vis Sci 43: 1897-1902, 2002.
4. Carré DA and Civan MM. cGMP modulates transport across the ciliary epithelium. J Membr Biol 146: 293-305, 1995.
5. Civan MM. Transport components of net secretion of the aqueous humor and their integrated regulation. In: The Eye's Aqueous Humor from Secretion to Glaucoma. New York: Academic, 1998. vol. 45, p. 1-24. (Curr Topics Membranes)
6. + channel to net secretion of aqueous humor. J Exp Zool 279: 498-503, 1997.
7. Chang AT, Polansky JR, and Crook RB. Natriuretic peptide receptors on human trabecular meshwork cells. Curr Eye Res 15: 137-143, 1996.
8. Coffey KL, Krushinsky A, Green CR, and Donaldson PJ. Molecular profiling and cellular localization of connexin isoforms in the rat ciliary epithelium. Exp Eye Res 75: 9-21, 2002.
9. + antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties. Mol Pharmacol 44: 1041-1045, 1993.
10. Crook RB and Chang AT. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells. Biochem J 324: 49-55, 1997.
11. Delporte C, Winand J, Poloczek P, Von Geldern T, and Christophe J. Discovery of a potent atrial natriuretic peptide antagonist for ANPA receptors in the human neuroblastoma NB-OK-1 cell line. Eur J Pharmacol 224: 183-188, 1992.
12. Dunn JJ, Lytle C, and Crook RB. Immunolocalization of the Na-K-Cl cotransporter in bovine ciliary epithelium. Invest Ophthalmol Vis Sci 42: 343-353, 2001.
13. Fenrick R, Babinski K, McNicoll N, Therrien M, Drouin J, and De Lean A. Cloning and functional expression of the bovine natriuretic peptide receptor-B (natriuretic factor R1c subtype). Mol Cell Biochem 137: 173-182, 1994.
14. Fernández-Durango R, Moya FJ, Ripodas A, de Juan JA, Fernández-Cruz A, and Bernal R. Type B and type C natriuretic peptide receptors modulate intraocular pressure in the rabbit eye. Eur J Pharmacol 364: 107-113, 1999.
15. Fernández-Durango R, Nuñez DJ, and Brown MJ. Messenger RNAs encoding the natriuretic peptides and their receptors are expressed in the eye. Exp Eye Rex 61: 723-729, 1995.
16. Fernández-Durango R, Ramirez JM, Trivino A, Sanchez D, Paraiso P, Garcia DL, Ramirez A, Salazar JJ, Fernandez-Cruz A, and Gutkowska J. Experimental glaucoma significantly decreases atrial natriuretic factor (ANF) receptors in the ciliary processes of the rabbit eye. Exp Eye Res 53: 591-596, 1991.
17. i. Dev Genet 24: 123-136, 1999.
18. Ghosh S, Freitag AC, Martin-Vasallo P, and Coca-Prados M. Cellular distribution and differential gene expression of the three alpha subunit isoforms of the Na,K-ATPase in the ocular ciliary epithelium. J Biol Chem 265: 2935-2940, 1990
19. +-ATPase genes reveals a gradient of isoforms along the nonpigmemed ciliary epithelium: functional implications in aqueous humor secretion. J Cell Physiol 149: 184-194, 1991.
20. Goldmann DB and Waubke N. A pilot study on the effect of atrial natriuretic peptide on intraocular pressure in the human. Fortschr Ophthalmol 86: 494-496, 1989.
21. + antiporter. Analysis of phosphorylation and subcellular localization. J Biol Chem 269: 8741-8748, 1994.
22. Hammond TG, Yusufi AN, Knox FG, and Dousa TP. Administration of atrial natriuretic factor inhibits sodium-coupled transport in proximal tubules. J Clin Invest 75: 1983-1989, 1985.
23. Man Z, Wax MB, and Patil RV. Potential role of aquaporins and atrial natriuretic peptides in the aqueous humor dynamics. Exp Eye Res 67: 251-253, 1998.
24. + exchangers. Ann NY Acad Sci 976: 248-258, 2002.
25. Kirchhoff P, Wagner CA, Gaetzschmann F, Radebold K, and Geibel JP. Demonstration of a functional apical sodium hydrogen exchanger in isolated rat gastric glands. Am J Physiol Gastrointest Liver Physiol 285: G1242-G1248, 2003.
26. Kourie JI and Rive MJ. Role of natriuretic peptides in ion transport mechanisms. Med Res Rev 19: 75-94, 1999.
27. - on cell composition of rabbit ciliary epithelium: a new model for aqueous humor secretion. Invest Ophthalmol Vis Sci 39: 1631-1641, 1998.
28. McLaughlin CW, Zellhuber-McMillan S, Peart D, Purves RD, Macknight AD, and Civan MM. Regional differences in ciliary epithelial cell transport properties. J Membr Biol 182: 213-222, 2001.
29. a.Millar JC, Shahidullah M, and Wilson WS. Atriopeptin lowers aqueous humor formation and intraocular pressure and elevates ciliary cyclic GMP but lacks uveal vascular effects in the bovine perfused eye. J Ocul Pharmacol Ther 13: 1-11, 1997.
30. + exchanger isoforms. Am J Physiol Cell Physiol 268: C283-C296, 1995.
31. Noma A and Tsuboi N. Dependence of junctional conductance on proton, calcium and magnesium ions in cardiac paired cells of guinea-pig. J Physiol 382: 193-211, 1987.
32. Ortego J and Coca-Prados M. Functional expression of components of the natriuretic peptide system in human ocular nonpigmented ciliary epithelial cells. Biochem Biophys Res Commun 258: 21-28, 1999.
33. Pang IH, Shade DL, Matsumoto S, Steely HT, and DeSantis L. Presence of functional type B natriuretic peptide receptor in human ocular cells. Invest Ophthalmol Vis Sci 37: 1724-1731, 1996.
34. Pedersen S, Hoffmann EK, Hougaard C, and Lambert IH. Cell shrinkage is essential in lysophosphatidic acid signaling in Ehrlich ascites tumor cells. J Membr Biol 173: 19-29, 2000.
35. Rubattu S and Volpe M. The atrial natriuretic peptide: a changing view. J Hypertens 19: 1923-1931, 2001.
36. Russell KR and Potter DE. Dynorphin modulates ocular hydrodynamics and releases atrial natriuretic peptide via activation of kappa-Opioid receptors. Exp Eye Res 75: 259-270, 2002.
37. Salzmann J, Flitcroft D, Bunce C, Gordon D, Wormald R, and Migdal C. Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour. Br J Ophthalmol 82: 830-834, 1998.
38. Samuelsson-Almen M, Nilsson SF, Maepea O, and Bill A. Effects of atrial natriuretic factor (ANF) on intraocular pressure and aqueous humor flow in the cynomolgus monkey. Exp Eye Res 53: 253-260, 1991.
39. Seewald S, Sachinidis A, Dusing R, Ko Y, Seul C, Epping P, and Vetter H. Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells. Atherosclerosis 130: 121-131, 1997.
40. Shahidullah M and Wilson WS. Atriopeptin, sodium azide and cyclic GMP reduce secretion of aqueous humour and inhibit intracellular calcium release in bovine cultured ciliary epithelium. Br J Pharmacol 127: 1438-1446, 1999.
41. + in isolated, perfused colonic crypts. Proc Natl Acad Sci USA 92: 11573-11577, 1995.
42. Soltau JB and Zimmerman TJ. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol 1: S2-S5, 2002.
43. Sudoh T, Kangawa K, Minamino N, and Matsuo H. A new natriuretic peptide in porcine brain. Nature 332: 78-81, 1988.
44. Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, and Nakao K. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 133: 3038-3041, 1993.
45. Takashima Y, Taniguchi T, Yoshida M, Hague MS, Igaki T, Itoh H, Nakao K, Honda Y, and Yoshimura N. Ocular hypotension induced by intravitreally injected C-type natriuretic peptide. Exp Eye Res 66: 89-96, 1998.
46. Tremblay J, Desjardins R, Hum D, Gutkowska J, and Hamet P. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem 230: 31-47, 2002.
47. Tunny TJ, Richardson KA, Clark CV, and Gordon RD. The atrial natriuretic peptide gene in patients with familial primary open-angle glaucoma. Biochem Biophys Res Commun 223: 221-225, 1996.
48. Vesely DL. Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res 51: 647-658, 2001.
49. Wolfensberger TJ, Singer DR, Freegard T, Markandu ND, Buckley MG, and MacGregor GA. Evidence for a new role of natriuretic peptides: control of intraocular pressure. Br J Ophthalmol 78: 446-448, 1994.